OC8 The short‐term efficacy of osseointegrated implants in patients with non‐malignant oral mucosal disease: a case series

Abstract

Purpose The spectrum of patients who may wish or warrant osseointegrated implants is increasing, despite few reports of the impact of non‐malignant oral mucosal disease upon implant placement. This report details the implant placement outcomes in three patients with pre‐existing oral mucosal disease.Case reports A: Four implants were placed in the lower anterior region of a 78‐year‐old female with longstanding mucous membrane pemphigoid (MMP) in 2004. The MMP had resulted in extensive cicatrisation of the upper and lower buccal and labial vestibules. One implant failed to osseointegrate, but was successfully replaced. There have been no other postplacement adverse events, despite the MMP remaining mildly active. B: A 36‐years‐old male with orofacial granulomatosis characterised by recurrent lip swelling and gingival enlargement, had a single implant placed in the upper canine region in 2001. Although still in situ significant peri‐implant alveolar bone loss has occurred and has been stabilised by repeated debridement, local administration of topical minocycline and several courses of systemic metronidazole. C: A 53‐years‐old female with oral manifestations of diffuse systemic sclerosis and fibrosing alveolitis had four lower anterior mandibular implants placed in 1995 to support an 8 unit bridge. One episode of peri‐implant inflammation was controlled with local debridement and topical chlorhexidine mouthrinse. The implants remain satisfactory 11 years postinsertion.Conclusion The short‐term failure of osseointegrated implant integration appears uncommon in patients with non‐malignant oral mucosal disease. There remains a need to establish appropriate case selection criteria and monitor outcomes.